Focal Segmental Glomerulosclerosis (FSGS) Completed Phase 3 Trials for Mycophenolate mofetil (DB00688)

Also known as: Focal Glomerulosclerosis / Glomerulosclerosis, Focal / Focal Segmental Glomerulosclerosis / Glomerulosclerosis, Focal Segmental / APOL1-mediated focal segmental glomerulosclerosis / Focal & segmental glomerulosclerosis / Focal glomerular sclerosis (disorder) / Focal segmental glomerulosclerosis (disorder)

IndicationStatusPhase
DBCOND0038485 (Focal Segmental Glomerulosclerosis (FSGS))Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00404833Mycophenolate Mofetil in Membranous Nephropathy and Focal SegmentalTreatment